NRX Pharmaceuticals Inc to discuss the FDA meeting Transcript
Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals discusses FDA first-cycle review conference call. (Operator Instructions)
I would now like to turn the conference call over to Brian Korb from Astr Partners. Please go ahead.
Thank you, operator.
Before we begin, I'd like to remind everyone that certain statements made during today's call may be considered forward-looking statements within the meaning of applicable securities laws. These statements are based on management's current expectations and assumptions that are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from these expressed or implied. Please refer to the company's SEC filings and today's press release for a discussion of these risks. NRx Pharmaceuticals undertakes no obligation to update any forward-looking statements, except as required by law.
Joining us today are Dr. Jonathan Javitt, Founder, Chairman, and Chief Executive Officer of NRx
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
